| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Serina Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 95.7K | $957K | $10.00 | Mar 28, 2025 | Direct |
| Serina Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 490K | Sep 9, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SER | Serina Therapeutics, Inc. | Mar 28, 2025 | 1 | $0 | 4 | Apr 1, 2025 | Chief Executive Officer, Director |
| SER | Serina Therapeutics, Inc. | Sep 9, 2024 | 1 | $0 | 4 | Sep 11, 2024 | Chief Executive Officer, Director |
| SER | AgeX Therapeutics, Inc. | Mar 26, 2024 | 0 | $0 | 3 | Apr 3, 2024 | Interim CEO, Director |